SCM
MDGL icon

Sterling Capital Management’s Madrigal Pharmaceuticals MDGL Stock Holding History

Sterling Capital Management’s Portfolio MDGL Stock Details MDGL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$111K Buy
213
+91
+75% +$43.5K ﹤0.01% 1362
2025
Q4 		$71K Buy
122
+77
+171% +$39.3K ﹤0.01% 1661
2025
Q3 		$20.6K Buy
45
+4
+10% +$1.49K ﹤0.01% 2121
2025
Q2 		$12.4K Buy
41
+22
+116% +$6.55K ﹤0.01% 1993
2025
Q1 		$6.29K Buy
19
+1
+6% +$329 ﹤0.01% 2042
2024
Q4 		$5.55K Hold
18
– – ﹤0.01% 2432
2024
Q3 		$3.82K Buy
+18
New +$4.61K ﹤0.01% 1867

Other funds holding MDGL

BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
RI
RTW Investments New York $10B AUM 135.35% 1-Year Est. Return
ACA
Avoro Capital Advisors New York $10.2B AUM 149.19% 1-Year Est. Return
BlackRock
BlackRock New York $5.7T AUM 30.48% 1-Year Est. Return
PC
Paulson & Co New York $3.11B AUM 94.93% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return